BiotechTube
Sannova Analytical

Sannova Analytical

Somerset, United States· Est.
sannova.net
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Sannova Analytical is a privately held, revenue-generating contract research organization serving the pharmaceutical and biotech industries. It operates as a specialized service provider, leveraging state-of-the-art instrumentation and a team of expert scientists to deliver analytical data critical for drug development and regulatory submissions. With a strong track record of over 1,300 studies and a focus on complex therapeutics, Sannova positions itself as a high-quality, agile alternative to larger CROs. Its business model is entirely service-based, catering to a global client base of over 168 active customers.

Diagnostics

Technology Platform

Integrated analytical instrumentation platform including LC/MS/MS, Ion Mobility Spectrometry (TIMS), ICP/MS, HPLC, particle size analyzers, and stability chambers for bioanalytical and CMC testing.

Funding History

1
SeedUndisclosed

Opportunities

Growing demand for specialized CRO services due to increasing complexity of novel therapeutics (e.g., gene therapies, peptides) creates a need for advanced analytical platforms like Sannova's.
The trend of outsourcing by emerging biopharma companies, particularly those lacking internal analytical capabilities, provides a expanding client base for its boutique, full-service model.

Risk Factors

Intense competition from larger global CROs with greater resources and smaller niche labs.
High dependency on the overall health and R&D spending of the biopharma sector, making it vulnerable to economic downturns or funding cycles.
Operational and reputational risk associated with maintaining stringent regulatory compliance across all client studies.

Competitive Landscape

Sannova competes in the fragmented contract research organization market. It differentiates itself as a boutique, high-touch service provider against large, publicly-traded CROs (e.g., LabCorp, IQVIA, Charles River) and competes with other specialized analytical labs. Its key competitive advantages are its stated focus on quality, fast turnaround, flexibility, and expertise in complex bioanalysis.

More companies in Digital Health & Biotech SaaS →More companies in United States →